VDR and CYP27B1 are expressed in C2C12 cells and regenerating skeletal muscle: potential role in suppression of myoblast proliferation
- 15 August 2012
- journal article
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 303 (4) , C396-C405
Abstract
1α,25(OH)2D3, the active form of vitamin D3, has been reported to regulate the cell biology of skeletal muscle. However, there has been some controversy about the expression of the vitamin D receptor (VDR) and thus the potential role of vitamin D3 in skeletal muscle. In this study, we isolated and sequenced the full-length Vdr and Cyp27b1 transcripts in C2C12 myoblasts and myotubes. Western blots and immunocytochemistry confirmed protein expression in both myoblasts and myotubes clearly demonstrating that C2C12 cells express VDR and CYP27B1. To determine the vitamin D3 action, we found that C2C12 myoblasts treated with either 1α,25(OH)2D3 or 25(OH)D3 inhibited cell proliferation and this was associated with increased Vdr expression. The observation that treatment of C2C12 myoblasts with the inactive form of vitamin D3, [25(OH)D3], inhibited proliferation suggested that CYP27B1 was functionally active. We used small interfering RNA to knock down Cyp27b1 in myoblasts, and cells were treated with 25(OH)D3. The growth-suppressive effects of 25(OH)D3 were abolished, suggesting that CYP27B1 in myoblasts is necessary for the ability of 25(OH)D3 to affect cell proliferation. Finally, we analyzed expression of VDR and CYP27B1 in regenerating skeletal muscle in vivo. We found that expression of VDR and CYP27B1 increased significantly at day 7 of regeneration, and these results confirm the expression of Vdr and Cyp27b1 in vivo and suggest a potential role for vitamin D3 in skeletal muscle regeneration following injury.Keywords
This publication has 35 references indexed in Scilit:
- A non-canonical E-box within the MyoD core enhancer is necessary for circadian expression in skeletal muscleNucleic Acids Research, 2011
- Effective fiber hypertrophy in satellite cell-depleted skeletal muscleDevelopment, 2011
- 1,25(OH)2Vitamin D3 Stimulates Myogenic Differentiation by Inhibiting Cell Proliferation and Modulating the Expression of Promyogenic Growth Factors and Myostatin in C2C12 Skeletal Muscle CellsEndocrinology, 2011
- Differential Effects of Vitamin D Receptor Agonists on Gene Expression in Neonatal Rat CardiomyocytesCardiovascular Drugs and Therapy, 2011
- Vitamin D: newly discovered actions require reconsideration of physiologic requirementsTrends in Endocrinology & Metabolism, 2010
- 1,25(OH)2vitamin D3 inhibits cell proliferation by promoting cell cycle arrest without inducing apoptosis and modifies cell morphology of mesenchymal multipotent cellsThe Journal of Steroid Biochemistry and Molecular Biology, 2010
- 25-Hydroxyvitamin D3 is an agonistic vitamin D receptor ligandThe Journal of Steroid Biochemistry and Molecular Biology, 2010
- Antiproliferative action of menadione and 1,25(OH)2D3 on breast cancer cellsThe Journal of Steroid Biochemistry and Molecular Biology, 2009
- 1α,25-Dihydroxyvitamin D3 Reduces c-Myc Expression, Inhibiting Proliferation and Causing G1 Accumulation in C4-2 Prostate Cancer CellsEndocrinology, 2009
- Vitamin D in rheumatoid arthritisAutoimmunity Reviews, 2007